Back

MOYOM Biotech completes Cathay fund financing to support global growth

Verifying
  • MOYOM Biotech completed financing from the Cathay Consumer Co-Creation Fund.
  • Aphranel® has reached more than 700 medical aesthetics clinics across China since May 2025.
  • Aphranel® received NMPA registration in February 2025 and EU MDR certification in May 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.